Florence Meyer-Losic

DTS-108, A Novel Peptidic Prodrug of SN38: <i>In vivo</i> Efficacy and Toxicokinetic Studies

Florence Meyer-Losic, Céline Nicolazzi, Jérôme Quinonero et al. · Clinical Cancer Research · 2008 · 70 citations · Full text

Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.

Nicolas Guilbaud, Laurence Kraus‐Berthier, Florence Meyer-Losic et al. · PubMed · 2001 · 62 citations

Chemoprevention Strategy, Pathology, Human Solid Tumors +18

Improved Therapeutic Efficacy of Doxorubicin through Conjugation with a Novel Peptide Drug Delivery Technology (Vectocell)

Florence Meyer-Losic, Jérôme Quinonero, Vincent Dubois et al. · Journal of Medicinal Chemistry · 2006 · 53 citations

Preclinical Toxicity, Toxicokinetics, and Antitumoral Efficacy Studies of DTS-201, a Tumor-Selective Peptidic Prodrug of Doxorubicin

Denis Ravel, Vincent Dubois, Jérôme Quinonero et al. · Clinical Cancer Research · 2008 · 30 citations · Full text

STX140, but Not Paclitaxel, Inhibits Mammary Tumour Initiation and Progression in C3(1)/SV40 T/t-Antigen Transgenic Mice

Florence Meyer-Losic, Simon P. Newman, Joanna M. Day et al. · PLoS ONE · 2013 · 22 citations · Full text

Breast Oncology, Immunology, Pharmacotherapy +17